Maxim Nikolayevich Yakovlev - St. Petersburg entrepreneur, director of the Polygraphoformlenie group of companies, director of the European representative office of Unhwa biotechnology corporation and partner of the online project "EduMarket", which allows people interested in education to get the opportunity to develop their career, and also engage in personal growth .
The future entrepreneur was born on November 30, 1965 in the city of Temirtau (currently, the Republic of Kazakhstan).
The Polygraphoformleniye company, headed by Maxim Yakovlev since 1994, traces its history back to 1879, this time was marked by the creation of E.I. Marcus chromolithography in St. Petersburg, on Vasilyevsky Island. After the revolution of 1917, the enterprise was renamed the State Lithograph No. 3, and in 1974 it merged with the Printing Factory No. 17, after which a new name appeared - “Printing”. Finally, in 1994 Polygraphoformlenie OJSC was established, which at the moment is a group of companies.
Today the company is the largest in the North-West of Russia in the segment of label and packaging production, and the Polygraphoformlenie staff has more than five hundred employees.
The company works in four areas - offset production, the manufacture of self-adhesive labels, flexography and the creation of packaging by gravure printing.
Since 2002, the company joined the Global Packaging Alliance. This international organization includes companies from all over the world, such as Diamond Packaging, Goncalves, Colorpak, Cartmont and many others.
Today Polygraphoformlenie works with large customers, including many well-known brands, such as Baltika, Orimi Trade, Wrigley's, Nestle, Dirol, as well as JTI and BAT.
Biotechnology Unhwa
Maxim Yakovlev has been fascinated by the culture of the East for many years, and thanks to this passion he was able to establish business contacts in Asia. Since 2010, Yakovlev has been managing the European headquarters of the South Korean biotechnology corporation Unhwa, which is called Unhwa Europe LLC and is based in St. Petersburg.
The South Korean Biotechnology Corporation is developing a technology for the isolation of plant stem cells (Cambial meristematic cells) to produce active biological substances from them to create medicinal and prophylactic drugs, as well as natural cosmetics.
Experts from science and education institutions such as The Rockefeller University, Harvard Medecal School, as well as The University of Maryland for Integrative Medicine, confirm that this technology is a big step forward compared with traditional technologies for cultivating plant cells to produce natural products that previously faced with the problem of creating a mass production of biologically active substances from cultured plant cells.
The St. Petersburg representative office of the corporation, headed by Maxim Nikolayevich Yakovlev, is working to bring Unhwa biotechnology to the domestic market. The company plans to build a plant in Russia that will produce biologically active substances from plants.